Humulin 70/30 Cartridges (100 Units/mL)

Humulin 70/30 Cartridges (100 Units/mL) are for subcutaneous (under the skin) injection only. The 70/30 mix also available in vials.

Insulin is a hormone produced by the pancreas to manage blood sugar levels. It works by decreasing sugar in our blood and urine by increasing the uptake of sugar from the blood into the various tissues such as our muscles, liver, and fat.

For those with diabetes, our body either does not produce enough insulin or not at all. This is why insulin injections are necessary to keep blood sugar levels within a normal range.

Humulin 70/30 is used to treat patients diagnosed with type 1 and type 2 diabetes mellitus.

Humulin 70/30 combines both intermediate-acting (Humulin N) and short-acting insulin (Humulin R). It covers your insulin needs after meals, throughout the day, and during bedtime.

This insulin is produced using recombinant DNA processes. Due to its unique manufacturing process, Humulin differs from animal-source insulin but is structurally identical to that produced by the pancreas in our body.

https://www.google.com/search?q=Humulin+70%2F30+Cartridges+(100+Units%2FmL)&oq=Humulin+70%2F30+Cartridges+(100+Units%2FmL)&aqs=chrome..69i57j0i546l2j69i61.1099j0j9&sourceid=chrome&ie=UTF-8

Humulin 70/30 cartridges are not designed to allow any other insulin to be mixed in the cartridge.

Medication is administered through injection under the skin (subcutaneous) and duration can last between 16-18 hours. Humulin 70/30 Cartridges (100 Units/mL)

Humulin 70/30 is a fixed mixture of:

30% Humulin R Regular (insulin injection, human biosynthetic)
70% Humulin N NPH (insulin isophane, human biosynthetic)

Ensure you are ordering the correct insulin, as Humulin and Humalog can be easily mistaken with one another.

• Low blood sugar (hypoglycemia) is the most common side effect of insulin, including Lilly Humulin insulins. Signs of severe hypoglycemia can include: disorientation, unconsciousness, seizures, or death.
• Humulin KwikPens must never be shared, even if the needle is changed. If you use Humulin vials, you must never share needles or syringes with another person. Sharing poses a risk that you may give someone a serious infection or get a serious infection from them.
• Any change of insulin should be made cautiously and only under medical supervision.
• Changes in strength, manufacturer, type (eg, regular, NPH, analog), species, or method of manufacture may result in the need for a change in dosage.
• Some patients taking Humulin may require a change in dosage from that used with other insulins. If an adjustment is needed, it may occur with the first dose or during the first several weeks or months.
• High blood sugar (hyperglycemia) may develop if the body has too little insulin. In people with type 1 or insulin-dependent diabetes, prolonged hyperglycemia can result in diabetic ketoacidosis (DKA). DKA is a life-threatening emergency.
• Always check the carton and bottle label for the name and letter designation of the insulin received from the pharmacy to make sure it’s the correct insulin.
• Do not use any other insulin except on your healthcare provider’s advice and direction.
• Do not use Humulin after the expiration date stamped on the label or if it has been frozen.
• Do not share needles or syringes, because you may give or get an infection.